Aprea Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Aprea Therapeutics, Inc. (APRE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 21.19 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-12
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 21.19M shares, a 0.38% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 21.19M shares, a 0.64% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 21.19M shares, a 3.48% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 21.19M shares, a 1692.87% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 21.13M shares, a 252.08% increase from fiscal 2019.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 6.00M shares, a 419.98% increase from fiscal 2018.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 1.15M shares, a 0.11% increase from fiscal 2017.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 1.15M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | 21.19M shares 10-Q · filed 2021-08-12 | 21.19M shares 10-Q · filed 2021-08-12 | 21.19M shares derived: average of 3 quarters · filed 2021-08-12 | 21.19M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | 21.19M shares 10-Q · filed 2021-05-06 | 21.19M shares derived: average of 2 quarters · filed 2021-05-06 | 21.19M shares derived: average of 3 quarters · filed 2021-05-06 | 21.17M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-12-31 | 21.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 21.19M shares derived: average of 2 quarters · filed 2021-03-16 | 21.16M shares derived: average of 3 quarters · filed 2021-08-12 | 21.13M shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 21.19M shares 10-Q · filed 2020-11-06 | 21.15M shares derived: average of 2 quarters · filed 2021-08-12 | 21.12M shares 10-Q · filed 2020-11-06 | 20.96M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-06-30 | 21.11M shares 10-Q · filed 2021-08-12 | 21.08M shares 10-Q · filed 2021-08-12 | 20.88M shares derived: average of 3 quarters · filed 2021-08-12 | 15.95M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | 21.05M shares 10-Q · filed 2021-05-06 | 20.76M shares derived: average of 2 quarters · filed 2021-05-06 | 14.24M shares derived: average of 3 quarters · filed 2021-05-06 | 10.97M shares derived: average of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | 20.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 10.83M shares derived: average of 2 quarters · filed 2021-03-16 | 7.61M shares derived: average of 3 quarters · filed 2021-03-16 | 6.00M shares 10-K · filed 2021-03-16 |
| 2019-09-30 | 1.18M shares 10-Q · filed 2020-11-06 | 1.18M shares derived: average of 2 quarters · filed 2020-11-06 | 1.18M shares 10-Q · filed 2020-11-06 | 1.17M shares derived: average of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | 1.18M shares 10-Q · filed 2020-08-11 | 1.18M shares 10-Q · filed 2020-08-11 | 1.17M shares derived: average of 3 quarters · filed 2021-03-16 | 1.17M shares derived: average of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | 1.17M shares 10-Q · filed 2020-05-15 | 1.16M shares derived: average of 2 quarters · filed 2021-03-16 | 1.16M shares derived: average of 3 quarters · filed 2021-03-16 | |
| 2018-12-31 | 1.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 1.15M shares derived: average of 2 quarters · filed 2021-03-16 | 1.15M shares 10-K · filed 2021-03-16 | |
| 2018-09-30 | 1.15M shares 10-Q · filed 2019-11-14 | 1.15M shares 10-Q · filed 2019-11-14 | ||
| 2017-12-31 | 1.15M shares 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |